div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: ASM-2002 Marpdf · 75 patients 2027% HO Squint IC had squint 945% of these were concomitant 89 had optic atrophy at presentation Non-recordable ERG High Hypermetropia src=https:reader031fdocumentsusreader031viewer20220215115ac7f4cc7f8b9aa3298ba342html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: ASM-2002 Marpdf · 75 patients 2027% HO Squint IC had squint 945% of these were concomitant 89 had optic atrophy at presentation Non-recordable ERG High Hypermetropia src=https:reader031fdocumentsusreader031viewer20220215115ac7f4cc7f8b9aa3298ba342html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: ASM-2002 Marpdf · 75 patients 2027% HO Squint IC had squint 945% of these were concomitant 89 had optic atrophy at presentation Non-recordable ERG High Hypermetropia src=https:reader031fdocumentsusreader031viewer20220215115ac7f4cc7f8b9aa3298ba342html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: ASM-2002 Marpdf · 75 patients 2027% HO Squint IC had squint 945% of these were concomitant 89 had optic atrophy at presentation Non-recordable ERG High Hypermetropia src=https:reader031fdocumentsusreader031viewer20220215115ac7f4cc7f8b9aa3298ba342html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: ASM-2002 Marpdf · 75 patients 2027% HO Squint IC had squint 945% of these were concomitant 89 had optic atrophy at presentation Non-recordable ERG High Hypermetropia...